Christopher Posner

Christopher Posner

Chief Executive Officer at CARA THERAPEUTICS, INC.

Net worth: 164 274 $ as of 2024-03-30

54 year
Health Technology
Consumer Services
Retail Trade

Profile

Christopher A.
Posner
is currently the President, Chief Executive Officer & Director at CARA Therapeutics, Inc. Prior to his current position, he served as the President & Chief Executive Officer at Leo Pharma, Inc. from 2017 to 2021.
He also held the position of Head-Worldwide Commercial Operations at R-Pharm US LLC from 2014 to 2017.
Mr. Posner has an undergraduate degree from Villanova University and an MBA from The Fuqua School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-28 180,521 ( 0.33% ) 164 274 $ 2024-03-30

Christopher Posner active positions

CompaniesPositionStart
CARA THERAPEUTICS, INC. Chief Executive Officer 2021-11-08
All active positions of Christopher Posner

Former positions of Christopher Posner

CompaniesPositionEnd
Chief Executive Officer 2021-09-30
Corporate Officer/Principal 2016-12-31
ZEVRA THERAPEUTICS, INC. Director/Board Member -
See the detail of Christopher Posner's experience

Training of Christopher Posner

Villanova University Undergraduate Degree
The Fuqua School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Posner's experience

Connections

28

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
CARA THERAPEUTICS, INC.

Health Technology

ZEVRA THERAPEUTICS, INC.

Health Technology

Private companies2

Retail Trade

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Posner